Literature DB >> 1500197

Interleukin-2 receptors in experimental Chagas' disease.

D R Pakianathan1, R E Kuhn.   

Abstract

Mammals infected with the protozoan parasite Trypanosoma cruzi develop suppressed cellular and humoral immune responses. This immunosuppression has been correlated with reduced T-cell responses involving deficient interleukin-2 (IL-2) production and is apparently mediated primarily by suppressor macrophages. Various forms of immunosuppression in other systems have been associated with increased levels of soluble IL-2 receptors (sIL-2R), and in the present study levels of sIL-2R in the sera of T. cruzi-infected mice during the course of infection were examined in enzyme-linked immunosorbent assays. It was found that serum levels of sIL-2R were elevated only during the third week of acute infection, a time of intense immunosuppression. In addition, IL-2R on the surface of T cells were examined by flow cytometric analyses to determine whether there is an alteration in the number of IL-2R-positive cells and whether there is a change in expression of these receptors as infection progresses. The results revealed no significant change in the percentage of cells expressing IL-2R, nor did T cells become suppressed in their ability to express IL-2R in response to concanavalin A during the course of infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500197      PMCID: PMC257406          DOI: 10.1128/iai.60.9.3904-3908.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

2.  In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.

Authors:  M T Lotze; M C Custer; S O Sharrow; L A Rubin; D L Nelson; S A Rosenberg
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

3.  The released interleukin 2 receptor binds interleukin 2 efficiently.

Authors:  L A Rubin; G Jay; D L Nelson
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

4.  Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.

Authors:  R L Tarleton; R E Kuhn
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

Authors:  S G Reed
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2.

Authors:  A Harel-Bellan; M Joskowicz; D Fradelizi; H Eisen
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

7.  Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.

Authors:  A Harel-Bellan; M Joskowicz; D Fradelizi; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

Authors:  M S Loughnan; C J Sanderson; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Authors:  F Herrmann; S A Cannistra; H Levine; J D Griffin
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.